Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects
Crossref DOI link: https://doi.org/10.1007/s00702-018-1876-2
Published Online: 2018-03-22
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Riederer, Peter
Müller, Thomas
Text and Data Mining valid from 2018-03-22
Article History
Received: 19 December 2017
Accepted: 12 March 2018
First Online: 22 March 2018